Device Trial Radar · NCT02368080
Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults
Last checked: Nov 19, 2026Latest source record: Jul 30, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
95
Actual
Start
Apr 2013
Primary completion
Dec 2013
Study completion Jan 2014
Sponsor
- Lead sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de LouvainAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 20, 2015
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study compares the lung clearance index (LCI) in cystic fibrosis and healthy adults obtained with two different multiple breath nitrogen washout (MBWN2) devices. Each participants will perform the test (LCI) in duplicate on each device.
Conditions
- Cystic Fibrosis
- Healthy
Interventions
Comparison of two MBWN2 devices : "EasyOne Pro Lab" versus "Exhalyzer D"Device
Healthy and Cystic Fibrosis participants will perform the same day MBWN2 tests in duplicate with each device.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Lung Clearance Index (LCI)Time frame: 1 hour
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Cliniques universitaires Saint-Luc
Brussels, Belgium
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.